A Randomized, Double-Blind Study of GT160-246 Versus Vancomycin in Patients with C. Difficile-Associated Diarrhea

Grants and Contracts Details

StatusFinished
Effective start/end date4/16/02 → 2/28/05

Funding

  • GelTex Pharmaceuticals Inc: $4,656.00